Chief Operating Officer · Pacira BioSciences, Inc. (PCRX)

Daryl Gaugler

FY2022 is the first fiscal year CompBrief holds for Daryl Gaugler as a named executive officer of Pacira BioSciences; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$2,291,396

Salary $469,942Stock awards $766,131Bonus $287,900

2nd of 5 named executive officers at Pacira BioSciences by FY2022 total.

5 named officers on file for Pacira BioSciences, FY2022

Daryl Gaugler’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 2 equity grants, each cited to its filing
  • PCRX’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Pacira BioSciences’s whole pay program stands against its peers

  • Pacira BioSciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on PCRX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 21, 2023 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Daryl Gaugler’s full pay file as a PDF — free

More than this page: up to 10 years of Daryl’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Daryl Gaugler compensation by year

Pacira BioSciences Summary Compensation Table · the one fiscal year held
In US dollars, as Pacira BioSciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022
Salary$469,942
Bonus$287,900
Stock awards$766,131
Option awards$746,490
Non-equity incentive$0
Pension and deferred compensation$0
All other$20,933
Total$2,291,396

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Pacira BioSciences, Inc. DEF 14A filed April 21, 2023, accession 0001104659-23-048374, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Pacira BioSciences, Inc. filed document, accession 0001104659-23-048374. Every figure is read from that document and cited to the page and table it appears in. Filed April 21, 2023.

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
RSU12,900$498,069—
RSU4,500$173,745—
RSU4,000$154,440—
Option29,800—$59.39
Option9,373—$60.96
Option3,750—$52.37
Option7,500—$47.65
Option2,500—$42.54

Per the Outstanding Equity Awards at Fiscal Year-End table in Pacira BioSciences, Inc.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

1 Form 4 line since the FY2022 proxy (filed April 21, 2023)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2024-12-31Grant or award—243.54$16.01115,443.49

The 1 most recent of 1 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Pacira BioSciences’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
David StackChief Executive Officer$6,851,340
Daryl Gaugler · this pageChief Operating Officer$2,291,396
Anthony MolloyChief Legal and Compliance Officer$2,053,773
Kristen WilliamsChief Administrative Officer and Secretary$2,008,835
Charles Reinhart IIIChief Financial Officer$1,751,228

The full Pacira BioSciences compensation record

free company brief

This page is one person within Pacira BioSciences's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Pacira BioSciences proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Pacira BioSciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Daryl Gaugler's compensation dossier · One-time report. No refunds.